The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111302825 11130282 5 F 20150414 20160822 20150522 20160829 EXP CA-ROCHE-1580601 ROCHE 55.87 YR M Y 0.00000 20160829 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111302825 11130282 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062/S0060A,S0003B 103976 300 MG SOLUTION FOR INJECTION
111302825 11130282 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062/S0060A,S0003B 103976 300 MG SOLUTION FOR INJECTION
111302825 11130282 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062/S0060A,S0003B 103976 SOLUTION FOR INJECTION
111302825 11130282 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062/S0060A,S0003B 103976 SOLUTION FOR INJECTION
111302825 11130282 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062/S0060A,S0003B 103976 SOLUTION FOR INJECTION
111302825 11130282 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062/S0060A,S0003B 103976 SOLUTION FOR INJECTION
111302825 11130282 7 SS DIOVAN VALSARTAN 1 Oral U 0
111302825 11130282 8 SS PREDNISONE. PREDNISONE 1 Unknown 0
111302825 11130282 9 SS PREDNISONE. PREDNISONE 1 Oral 0
111302825 11130282 10 SS PREDNISONE. PREDNISONE 1 Oral 5 DAY COURSE 0 50 MG QD
111302825 11130282 11 SS PREDNISONE. PREDNISONE 1 Oral 5 DAY COURSE 0 50 MG
111302825 11130282 12 SS PREDNISONE. PREDNISONE 1 Oral 10 DAY COURSE 0 50 MG
111302825 11130282 13 SS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown U 0 18 UG
111302825 11130282 14 C PANTOLOC PANTOPRAZOLE SODIUM 1 Unknown 0
111302825 11130282 15 C ALENDRONATE ALENDRONATE SODIUM 1 Unknown 0
111302825 11130282 16 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Unknown 0
111302825 11130282 17 C IPRATROPIUM IPRATROPIUM 1 Unknown 0
111302825 11130282 18 C SINGULAIR MONTELUKAST SODIUM 1 Unknown 0
111302825 11130282 19 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown 0
111302825 11130282 20 C VENTOLIN ALBUTEROL SULFATE 1 Unknown 0
111302825 11130282 21 C METHOTREXATE. METHOTREXATE 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111302825 11130282 1 Asthma
111302825 11130282 7 Product used for unknown indication
111302825 11130282 8 Product used for unknown indication
111302825 11130282 13 Product used for unknown indication
111302825 11130282 14 Product used for unknown indication
111302825 11130282 15 Product used for unknown indication
111302825 11130282 16 Product used for unknown indication
111302825 11130282 17 Product used for unknown indication
111302825 11130282 18 Product used for unknown indication
111302825 11130282 19 Product used for unknown indication
111302825 11130282 20 Product used for unknown indication
111302825 11130282 21 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
111302825 11130282 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
111302825 11130282 Asthma
111302825 11130282 Asthma-chronic obstructive pulmonary disease overlap syndrome
111302825 11130282 Blood pressure systolic increased
111302825 11130282 Chest discomfort
111302825 11130282 Cough
111302825 11130282 Cushing's syndrome
111302825 11130282 Dyspnoea
111302825 11130282 Dyspnoea exertional
111302825 11130282 Forced expiratory volume decreased
111302825 11130282 Heart rate increased
111302825 11130282 Hypoventilation
111302825 11130282 Obstructive airways disorder
111302825 11130282 Productive cough
111302825 11130282 Respiratory tract congestion
111302825 11130282 Restrictive pulmonary disease
111302825 11130282 Sensitivity to weather change
111302825 11130282 Sputum discoloured
111302825 11130282 Stress
111302825 11130282 Upper respiratory tract infection
111302825 11130282 Weight decreased
111302825 11130282 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111302825 11130282 1 20120425 0
111302825 11130282 2 20150112 0
111302825 11130282 3 20160113 0
111302825 11130282 4 20160309 0
111302825 11130282 5 20160727 0
111302825 11130282 6 20160822 0
111302825 11130282 8 201508 0
111302825 11130282 9 201509 0
111302825 11130282 10 201511 0
111302825 11130282 11 201602 0
111302825 11130282 13 201510 0